Is stem cell therapy for joints the same as the unregulated injections I've heard about?
No — and this distinction matters. There is a significant difference between the unregulated "stem cell" injections offered by some US clinics (which are not FDA-approved and lack clinical oversight) and the government-regulated, clinically administered protocols available at accredited hospitals in South Korea, Japan, and Cyprus. The facilities we work with operate under national regulatory frameworks, apply defined clinical protocols, and perform proper patient evaluation before treating anyone.
Will this prevent me from needing surgery?
That's the goal for many patients — but we can't guarantee it, and neither can any provider. For eligible candidates, regenerative treatment may meaningfully reduce pain, improve function, and delay or avoid surgery. For others, it may provide temporary improvement or limited benefit. The honest answer depends entirely on your specific injury, severity, age, and overall health. The specialist evaluation will give you a realistic picture before you commit to anything.
How do I know if I'm a good candidate?
Candidacy is determined after reviewing your MRI or X-ray imaging, medical history, and current symptoms. In general terms, patients with Grade I–III joint damage, partial tendon or ligament injuries, and chronic pain from identifiable structural damage tend to be more suitable candidates. Grade IV (bone-on-bone) joint damage may or may not qualify depending on the protocol. Submit your case — the evaluation team will give you an honest assessment.
How long do I need to stay in-country?
Most stem cell orthopedic procedures are performed in a single session — either same-day arthroscopic or injection-based. Patients typically plan 7–12 days total: pre-procedure evaluation, the procedure, and initial monitored recovery before flying home. Your coordinator will provide a specific timeline once your case is reviewed. PRP-only treatments may require a shorter stay.
What does it cost compared to the US or Europe?
In the US, stem cell orthopedic treatments — where available — typically cost $5,000–$15,000 or more, and are rarely covered by insurance. In Europe, similar limitations on insurance coverage apply and costs are comparable. At partner facilities abroad, the same caliber of treatment is often available for significantly less — sometimes 50–70% of what you'd pay at home. All figures are estimates until confirmed by the provider after reviewing your case.
When will I notice results?
Stem cell therapy works over time — not immediately. Most patients notice early changes at 6–8 weeks, with more significant improvement at 3–4 months. Full benefit is typically assessed at 6–12 months. The timeline varies by injury type, severity, and patient health. We set these expectations clearly before you travel, so you're not surprised by a process that requires patience.
I'm in Europe — which destination makes the most sense for me?
For European patients, Cyprus is often the most convenient option — short flight times from most European capitals, European regulatory standards, and a well-established program at SwissMed Health in Limassol. Turkey is also easily accessible from Europe and offers strong clinical infrastructure with significant cost advantages. South Korea and Japan require longer travel but are worth considering if your injury profile benefits specifically from those destinations' stronger clinical track records.
